Thomas Clozel - Co-Founder & CEO @ Waiv - Crunchbase Person Profile

Start Free Trial

Pricing

Overview

Number of Portfolio Companies

Number of Exits

Unlock for free

Primary Job Title Co-Founder & CEO
Primary Organization
Waiv

Location New York, New York, United States
Regions Greater New York Area, East Coast, Northeastern US
Gender Male

Investor Type
obfuscated
obfuscation
Number of Exits
obfuscated
obfuscation

LinkedIn View on LinkedIn
X (Twitter) View on X

Thomas Clozel is based out of New York, New York and is the CEO and Co-founder of Waiv. Thomas previously worked at Fragment as a Seed Investor. Thomas Clozel attended the Joan & Sanford I. Weill Medical College of Cornell University.

Personal Investments

Number of Investments

Thomas Clozel

has made

investments. Their latest investment was

Seed Round - Modern Relay

obfuscation

, when

Modern Relay

raised

obfuscation

Announced Date	Organization Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Modern Relay	—	Seed Round - Modern Relay	obfuscated obfuscation
obfuscated obfuscation	altrove AI	—	Seed Round - altrove AI	obfuscated obfuscation
obfuscated obfuscation	Grâce	—	Seed Round - Grâce	obfuscated obfuscation
obfuscated obfuscation	altrove AI	—	Pre Seed Round - altrove AI	obfuscated obfuscation
obfuscated obfuscation	Callyope	—	Seed Round - Callyope	obfuscated obfuscation
obfuscated obfuscation	Osium AI	—	Seed Round - Osium AI	obfuscated obfuscation
obfuscated obfuscation	Dioxycle	—	Seed Round - Dioxycle	obfuscated obfuscation
obfuscated obfuscation	Resilience	—	Seed Round - Resilience	obfuscated obfuscation
obfuscated obfuscation	Spot - justspot.io	—	Seed Round - Spot - justspot.io	obfuscated obfuscation
obfuscated obfuscation	Patch Biosciences	—	Seed Round - Patch Biosciences	obfuscated obfuscation

Exits

Number of Exits

Unlock for free

Thomas Clozel

has

obfuscation

exit -

Patch Biosciences

Thomas Clozel

has

obfuscation

exits. Their most notable exits are

Patch Biosciences

Patch Biosciences Patch Biosciences is a synthetic biology and machine learning company with a platform to engineer gene therapies and medicine.

Jobs

Number of Current Jobs

Thomas Clozel

has

current jobs including

Co-founder and Executive Chairman

Septhom

Non operational cofounder

Cure51

, and

Non operational cofounder and Board Dlrector

Bioptimus

Septhom Co-founder and Executive ChairmanJan 2025
Cure51 Non operational cofounderMar 2024
Bioptimus Non operational cofounder and Board DlrectorFeb 2024
Waiv Co-Founder & CEOJun 2016

Related Hubs

Hub Name	CB Rank (Hub)
Pontifical Catholic University of Rio de Janeiro Alumni Founded Companies	71,039
Augsburg University Alumni Founded Companies	92,986
University of Alabama Alumni Founded Companies	60,564
Universidad de Los Andes Alumni Founded Companies	64,720
University of Washington Michael G. Foster School of Business Alumni Founded Companies	59,608
Open University in Hagen Alumni Founded Companies	82,846
Marshall University Alumni Founded Companies	84,223
UCLA School of Law Alumni Founded Companies	80,781
Paris-Sorbonne University Alumni Founded Companies	54,035
Rutgers University Alumni Founded Companies	31,881